Lumateperone was associated with a 63% lower risk for relapse and was well-tolerated among patients with schizophrenia.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/lumateperone-linked-lower-risk-schizophrenia-relapse-2026a1000jul?src=rss
Author :
Publish date : 2026-06-12 13:06:00
Copyright for syndicated content belongs to the linked Source.